Avidity Biosciences, Inc. Ratios

Ratios Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Profitability
EBT Margin -2,959.37%-1,065.93%-652.42%-1,264.71%-1,885.71%-2,213.66%-2,955.44%
EBIT Margin -2,769.92%-747.39%-652.38%-1,265.83%-1,939.65%-2,464.41%-3,477.43%
EBITDA Margin -2,959.37%-1,066.58%-653.60%-1,267.33%-1,913.55%-2,190.35%-2,932.23%
Operating Margin -2,769.92%-747.39%-652.38%-1,265.83%-1,939.65%-2,464.41%-3,477.43%
Net Margin -2,959.37%-1,065.93%-652.42%-1,264.71%-1,885.71%-2,213.66%-2,955.44%
FCF Margin -2,560.42%97.24%-562.97%-1,056.76%-1,507.92%-1,289.67%-2,825.88%
Efficiency
Assets Average 215.40M380.74M533.19M633.68M1,096.22M
Equity Average 120.43M343.83M479.75M539.42M962.86M
Invested Capital -62.58M306.22M381.43M578.08M500.76M1,424.96M
Asset Utilization Ratio 0.030.020.020.020.01
Leverage & Solvency
Interest Coverage Ratio -14.62-2.35-211.85
Debt to Equity -0.07
Debt Ratio 0.05
Equity Ratio -0.670.920.890.900.800.91
Times Interest Earned -14.62-2.35-211.85
Valuation
Enterprise Value -94.58M629.54M709.20M597.80M75.27M1,968.02M
Market Capitalization 957.68M1,114.74M1,208.52M670.62M3,469.51M
Return Ratios
Return on Sales -29.59%-10.66%-6.52%-12.65%-18.86%-22.14%-29.55%
Return on Capital Employed -0.22%-0.34%-0.37%-0.43%-0.38%
Return on Assets -0.21%-0.31%-0.33%-0.33%-0.29%
Return on Equity -0.37%-0.34%-0.36%-0.39%-0.33%